KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Non-cash Items (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Non-cash Items for 18 consecutive years, with $351.7 million as the latest value for Q1 2026.

  • For Q1 2026, Non-cash Items rose 48.77% year-over-year to $351.7 million; the TTM value through Mar 2026 reached $589.3 million, up 207.89%, while the annual FY2025 figure was $474.0 million, 5900.0% up from the prior year.
  • Non-cash Items hit $351.7 million in Q1 2026 for Regeneron Pharmaceuticals, up from $326.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.1 billion in Q1 2022 and bottomed at -$1.1 billion in Q2 2024.
  • Average Non-cash Items over 5 years is $126.5 million, with a median of $158.7 million recorded in 2025.
  • On a YoY basis, Non-cash Items climbed as much as 593.71% in 2024 and fell as far as 2096.85% in 2024.
  • Regeneron Pharmaceuticals' Non-cash Items stood at $522.8 million in 2022, then plummeted by 113.37% to -$69.9 million in 2023, then soared by 593.71% to $345.1 million in 2024, then fell by 5.51% to $326.1 million in 2025, then rose by 7.85% to $351.7 million in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $351.7 million, $326.1 million, and $158.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.